Dermatology news

NICE approves apremilast for refractory psoriasis

NICE approves apremilast for refractory psoriasis

In new guidance NICE recommends the use of apremilast...

Start brimonidine gel at low dose in rosacea, cautions MHRA

Start brimonidine gel at low dose in rosacea, cautions MHRA

Treatment with the topical rosacea treatment brimonidine...

Hidradenitis suppurativa treatment accepted for NHS use

Hidradenitis suppurativa treatment accepted for NHS use

Adalimumab (Humira) has been approved by NICE for patients...

New immunomodulator for systemic treatment of psoriasis

New immunomodulator for systemic treatment of psoriasis

Ixekizumab is a monoclonal antibody that binds to and...

New vitamin D/steroid combination foam for psoriasis

New vitamin D/steroid combination foam for psoriasis

Enstilar is a topical foam formulation of calcipotriol...

Talimogene laherparepvec: first oncolytic virus launched as treatment for unresectable melanoma

Talimogene laherparepvec: first oncolytic virus launched as treatment for unresectable melanoma

Imlygic (talimogene laherparepvec) is licensed to treat...

First etanercept biosimilar available to prescribe

First etanercept biosimilar available to prescribe

Benepali (etanercept) launches this week, providing...

Trametinib, a new protein kinase inhibitor for BRAF V600 positive melanoma

Trametinib, a new protein kinase inhibitor for BRAF V600 positive melanoma

Mekinist (trametinib) can be used as monotherapy or...

NICE rejects oral psoriasis treatment

Green tea ointment launched for genital warts

Green tea ointment launched for genital warts

Catephen is a herbal medicinal product licensed for...

Psoriasis treatment secukinumab approved by NICE

Psoriasis treatment secukinumab approved by NICE

The monoclonal antibody secukinumab (Cosentyx) has...

MIMS Clinical Update in Manchester

MIMS Clinical Update in Manchester

If you missed our successful MIMS Clinical Update in...

New topical treatment option for rosacea

New topical treatment option for rosacea

Soolantra (ivermectin) is thought to alleviate papulopustular...

MIMS Dermatology workshop on actinic keratosis

MIMS Dermatology workshop on actinic keratosis

A complimentary full-day MIMS workshop focussing on...

Hydroxyzine: risk of QT prolongation and torsade de pointes

Hydroxyzine: risk of QT prolongation and torsade de pointes

Prescribing recommendations for the use of hydroxyzine...

Humira now licensed for psoriasis treatment in children

Humira now licensed for psoriasis treatment in children

Humira (adalimumab) is now licensed for the treatment...

Cosentyx: a new option in plaque psoriasis

Cosentyx: a new option in plaque psoriasis

Novartis has launched Cosentyx (secukinumab), the first...

Otezla: new treatment for psoriasis and psoriatic arthritis

Otezla: new treatment for psoriasis and psoriatic arthritis

Celgene has launched Otezla (apremilast) for use in...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.